Intrexon Corporation, líder en biología sintética, anunció la formación de Intrexon Crop Protection (ICP), una subsidiaria de propiedad absoluta dedicada al control biológico de plagas y enfermedades agrícolas, incluidos insectos y hongos.
Through the utilization of two proprietary technologies within Intrexon’s platform, ICP’s approach will precisely target single pest species avoiding the off-target effects of conventional pesticide applications on the broader ecosystem.
Intrexon dijo que tiene la intención de que ICP se convierta en una empresa pública independiente.
Randal J. Kirk, Intrexon’s Chairman and CEO stated, “Considering the robustness of our engineered biological crop protection solutions pipeline, the interest received in each of our two contributing platforms, the scarcity of other workable new technologies, the ongoing consolidation of the mature companies in the sector, the increasing reliance by food growers on a decreasingly effective set of marketed solutions, the enormous size of the available markets for better crop protection solutions and the efficiencies that we believe will be realized by marshalling development of the resultant products under one enterprise management team, I am pleased to announce this milestone event in our company’s history.”
“The newly formed Intrexon Crop Protection subsidiary will utilize Intrexon’s platforms to help protect growers’ crops through biological control of agricultural pests, highlighted by a fully differentiated self-limiting insect platform and a proprietary approach for the expression of nucleic acids and peptides,” said Corey Huck, SVP and Head of Intrexon’s Food Sector. “The protection of harvests is critical given population growth and the declining efficiency of traditional practices.”
Cada año, hasta 16% de la producción mundial de cultivos se pierde debido a daños causados por plagas y enfermedades agrícolas, y los informes de la industria estiman que los mercados de insecticidas y fungicidas alcanzarán un total combinado de $40 mil millones para 2019. Resistencia creciente a varios enfoques, incluidos pesticidas químicos y Los cultivos modificados genéticamente están creando desafíos adicionales para la industria. Además, varios plaguicidas químicos útiles se han eliminado o se están eliminando gradualmente debido a las preocupaciones sobre su impacto negativo en la salud humana, el ganado y el medio ambiente.
ICP is centered on cutting-edge technologies that have the potential to improve agricultural productivity in an environmentally friendly manner, driving value for growers and consumers alike. To this end, ICP will employ Oxitec’s diverse self-limiting gene platform for insect control as well as the ActoBioticsLactococcus lactis sistema para la expresión de productos biológicos específicos para desarrollar programas de manejo de plagas y enfermedades agrícolas específicas para cada especie.
ICP’s pipeline of insect and fungal control programs will offer protection in both large acre row crops and high value specialty crops such as fruits and vegetables. These solutions are in various stages of development including ongoing as well as successfully completed field trials.
Sekhar Boddupalli, Ph.D., Intrexon’s current Vice President, Food and Nutrition, will serve as President of the new company from ICP’s Davis, California facility. Also joining ICP will be Simon Warner, Ph.D., Oxitec’s current Chief Science Officer who will oversee research on self-limiting insects for both companies.
Supplemental information on ICP in the form of a slide presentation is available in the Investors section of Intrexon’s website at http://investors.dna.com, and additional details regarding ICP will be shared on the company’s upcoming quarterly conference call scheduled for May 10ta, 2016.
Fuente: Intrexon